Jie Ling

1.3k total citations
18 papers, 981 citations indexed

About

Jie Ling is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, Jie Ling has authored 18 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in Jie Ling's work include bioluminescence and chemiluminescence research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Gastrointestinal disorders and treatments (2 papers). Jie Ling is often cited by papers focused on bioluminescence and chemiluminescence research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Gastrointestinal disorders and treatments (2 papers). Jie Ling collaborates with scholars based in United States, China and Switzerland. Jie Ling's co-authors include Edmund G. Lowrie, Glenn M. Chertow, J. Michael Lazarus, Nancy L. Lew, Hugh M. Davis, Honghui Zhou, Bert L. Lum, Marta Hamilton, Ashok Rakhit and Qun Jiao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and RSC Advances.

In The Last Decade

Jie Ling

16 papers receiving 929 citations

Peers

Countries citing papers authored by Jie Ling

Since Specialization

Citations

This map shows the geographic impact of Jie Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ling more than expected).

Fields of papers citing papers by Jie Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ling. The network helps show where Jie Ling may publish in the future.

Co-authorship network of co-authors of Jie Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ling. A scholar is included among the top collaborators of Jie Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ling. Jie Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Engineering ion channels for ultrahigh mercury sensitivity: Visual detection at critical environmental limits 2025 ·Ecotoxicology and Environmental Safety ·Jinping Ou, (unknown), Jie Tang, (unknown), Can Wu, Jie Ling, (unknown), Zhenlie Huang, Chang-ye Hui	0
2	Development of a user-friendly IdgS-Sfp based whole-cell biosensor for high-performance Hg(II) detection in environmental samples 2025 ·Microchemical Journal ·(unknown), Yan Guo, (unknown), Hui Li, Jie Tang, Jie Ling, Jianyin Xiong, Jinping Ou, Chang-ye Hui	0
3	Repurposing the Sb(III)-specific efflux and sequestration system (ant operon) to mitigate antimonite cross-talk in ArsR-based bacterial arsenite sensors 2025 ·Microbial Cell Factories ·Jie Ling, (unknown), Mingqi Liu, (unknown), (unknown), Xueqin Yang, Xuli Wu, Chang-ye Hui	1
4	Pyomelanin-powered whole-cell biosensor for ultrasensitive and selective detection of bioavailable Hg(ii) 2025 ·RSC Advances ·Jie Tang, Chang-ye Hui, (unknown), (unknown), Peihua Cao, Jie Ling, Xueqin Yang, Zhenlie Huang, Yan Guo	1
5	Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer 2014 ·Anti-Cancer Drugs ·Hilary Calvert, Chris Twelves, Malcolm Ranson, Ruth Plummer, Scott Fettner, Michael Pantze, Jie Ling, Marta Hamilton, Bert L. Lum, Ashok Rakhit	11
6	Recurrent lower gastrointestinal bleeding due to primary colonic Kaposi's sarcoma in a patient with AIDS 2013 ·International Journal of STD & AIDS ·Jie Ling, (unknown), (unknown), (unknown)	9
7	Recurrent Lower Gastrointestinal Bleeding: Ileal GIST Diagnosed by Video Capsule Endoscopy—A Case Report and Literature Review 2013 ·SHILAP Revista de lepidopterología ·Jie Ling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
8	Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma 2011 ·Investigational New Drugs ·Steven O’Day, Anna C. Pavlick, Mark R. Albertini, Omid Hamid, Heidi Schalch, Zhihui Lang, Jie Ling, Marielena Mata, Manjula Reddy, Brenda J. Foster	22
9	Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects 2010 ·The Journal of Clinical Pharmacology ·Jie Ling, (unknown), Zhenhua Xu, (unknown), Esther Bouman‐Thio, Akira Shishido, Joyce Ford, Gopi Shankar, Carrie Wagner, (unknown), Hugh M. Davis, Honghui Zhou	32
10	Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look 2009 ·The Journal of Clinical Pharmacology ·Jie Ling, Honghui Zhou, Qun Jiao, Hugh M. Davis	102
11	Population Pharmacokinetics of Golimumab, an Anti‐Tumor Necrosis Factor‐α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis 2009 ·The Journal of Clinical Pharmacology ·Zhenhua Xu, Thuy Vu, Howard Lee, Chuanpu Hu, Jie Ling, Hong Yan, Daniel Baker, Anna Beutler, Charles Pendley, Carrie Wagner, Hugh M. Davis, Honghui Zhou	80
12	Evaluation of the Absolute Oral Bioavailability and Bioequivalence of Erlotinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in a Randomized, Crossover Study in Healthy Subjects 2006 ·The Journal of Clinical Pharmacology ·Paul Frohna, Jianfeng Lu, Steve Eppler, Marta Hamilton, Julie Wolf, Ashok Rakhit, Jie Ling, (unknown), Bert L. Lum	82
13	OII-A-4Dose-proportionality assessment based on robust statistical methods 2006 ·Clinical Pharmacology & Therapeutics ·Jihao Zhou, (unknown), (unknown), Jie Ling, Michael Amantea, Susan Raber, Melvin Toh, Carlo L. Bello, Karen J. Klamerus, Randy Allred	1
14	METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS 2005 ·Drug Metabolism and Disposition ·Jie Ling, Kim A. Johnson, Zhuang Miao, Ashok Rakhit, Michael Pantze, Marta Hamilton, Bert L. Lum, Chandra Prakash	187
15	Predicting Hemodialysis Access Failure with Color Flow Doppler Ultrasound 1998 ·American Journal of Nephrology ·William H. Bay, (unknown), J. Michael Lazarus, Nancy L. Lew, Jie Ling, Edmund G. Lowrie	102
16	Effect of lithium in immunodeficiency: improved blood cell formation in mice with decreased hematopoiesis as the result of LP-BM5 MuLV infection 1995 ·Antiviral Research ·(unknown), (unknown), (unknown), Jie Ling, Nicholas J. Birch	12
17	Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. 1995 ·Journal of the American Society of Nephrology ·Glenn M. Chertow, Edmund G. Lowrie, Douglas W. Wilmore, Jorge González Arocha, (unknown), Jie Ling, Meryl S. LeBoff, M. N. Gottlieb, Weijie Huang, (unknown)	208
18	The Association of Intradialytic Parenteral Nutrition Administration with Survival in Hemodialysis Patients 1994 ·American Journal of Kidney Diseases ·Glenn M. Chertow, Jie Ling, Nancy L. Lew, J. Michael Lazarus, Edmund G. Lowrie	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact